A center for advanced cancer genetic testing and analysis
UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center
This study is looking at how advanced genetic tests can help doctors create personalized treatment plans for cancer patients by understanding the unique makeup of their tumors and how their bodies might respond to different therapies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11250260 on NIH RePORTER |
What this research studies
This research focuses on using advanced genetic testing techniques, such as RNA sequencing, to analyze cancer genomes and improve personalized treatment options for patients. By examining the genetic makeup of tumors, the project aims to provide critical insights into how specific therapies can be tailored to individual patients based on their unique cancer profiles. The research will also explore genetic factors that may influence drug metabolism and familial cancer predisposition, enhancing the understanding of cancer treatment and prevention.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients who are undergoing treatment and may benefit from personalized therapy based on their tumor's genetic characteristics.
Not a fit: Patients with non-cancerous conditions or those not undergoing cancer treatment may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized cancer treatments based on individual genetic profiles.
How similar studies have performed: Previous research has shown success in using genetic sequencing to inform cancer treatment decisions, indicating that this approach is both promising and validated.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Merker, Jason Derek — Univ of North Carolina Chapel Hill
- Study coordinator: Merker, Jason Derek
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.